Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Vidal, F. Loganzo, A. Oliveira, N. Hayward, A. Albino (1995)
Mutations and defective expression of the WAF1 p21 tumour‐suppressor gene in malignant melanomasMelanoma Research, 5
R. Zakut, R. Perlis, S. Eliyahu, Yosef Yarden, David Givol, S. Lyman, R. Halaban (1993)
KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.Oncogene, 8 8
A. Orr-Urtreger, A. Avivi, Y. Zimmer, D. Givol, Y. Yarden, P. Lonai (1990)
Developmental expression of c-kit, a proto-oncogene encoded by the W locus.Development, 109 4
Jian Zhang, S. Hagopian-Donaldson, G. Serbedzija, Jennifer Elsemore, D. Plehn-Dujowich, A. McMahon, R. Flavell, T. Williams (1996)
Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2Nature, 381
Suyun Huang, M. Luca, M. Gutman, D. McConkey, Keith Langley, Stewart Lyman, M. Bar‐eli (1996)
Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.Oncogene, 13 11
rgenM. Lehmann, B. Holzmann, E. Breitbart, P. Schmiegelow, G. RiethmÃ, Judith Johnson (1987)
Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000.Cancer research, 47 3
M. Luca, S. Xie, M. Gutman, S. Huang, M. Bar‐eli (1995)
Abnormalities in the CDKN2 (p16INK4/MTS-1) gene in human melanoma cells: relevance to tumor growth and metastasis.Oncogene, 11 7
J. Johnson, M. Bar‐eli, B. Jansen, E. Markhof (1997)
Melanoma progression-associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand.International journal of cancer, 73 5
K. Zsebo, David Williams, E. Geissler, V. Broudy, F. Martin, Harry Atkins, R. Hsu, N. Birkett, K. Okino, Douglas Murdock, F. Jacobsen, K. Langley, K. Smith, Takashi Takeish, B. Cattanach, S. Galli, S. Suggs (1990)
Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptorCell, 63
K. Descheemaeker, S. Wyns, L. Nelles, J. Auwerx, T. Ny, D. Collen (1992)
Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response.The Journal of biological chemistry, 267 21
L. Giebel, R. Spritz (1991)
Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.Proceedings of the National Academy of Sciences of the United States of America, 88 19
Richard Gaynor, Christian Muchardt, Yu-Rong Xia, Ivanna Klisak, T. Mohandas, Robert Sparkes, A. Lusis (1991)
Localization of the gene for the DNA-binding protein AP-2 to human chromosome 6p22.3-pter.Genomics, 10 4
I. Shih, David Elder, David Speicher, Judith Johnson, M. Herlyn (1994)
Isolation and functional characterization of the A32 melanoma-associated antigen.Cancer research, 54 9
B. Chabot, D. Stephenson, V. Chapman, P. Besmer, A. Bernstein (1988)
The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locusNature, 335
H. Schorle, P. Meier, M. Buchert, R. Jaenisch, P. Mitchell (1996)
Transcription factor AP-2 essential for cranial closure and craniofacial developmentNature, 381
S. Nishikawa, M. Kusakabe, K. Yoshinaga, M. Ogawa, S. Hayashi, T. Kunisada, T. Era, T. Sakakura, S. Nishikawa (1991)
In utero manipulation of coat color formation by a monoclonal anti‐c‐kit antibody: two distinct waves of c‐kit‐dependency during melanocyte development.The EMBO Journal, 10
I. Fidler (1990)
Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.Cancer research, 50 19
Rakesh Singh, J. Gershenwald, M. Gutman, Reuven Reich, M. Bar‐eli (1995)
Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8.Cancer research, 55 16
M. Bar‐eli (1997)
Molecular mechanisms of melanoma metastasisJournal of Cellular Physiology, 173
R. Fleischman, David Saltman, Victor Stastny, Susan Zneimer (1991)
Deletion of the c-kit protooncogene in the human developmental defect piebald trait.Proceedings of the National Academy of Sciences of the United States of America, 88 23
Maria Bani, Janusz Rak, Dena Adachi, R. Wiltshire, Jeffrey Trent, Robert Kerbel, Yaacov Ben-David (1996)
Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.Cancer research, 56 13
M. Luca, B. Hunt, C. Bucana, J. Johnson, Isaiah Fidler, M. Bar‐eli (1993)
Direct correlation between MUC18 expression and metastatic potential of human melanoma cells.Melanoma research, 3 1
J. Oord, N. Vandeghinste, M. Ley, C. Wolf‐Peeters (1994)
Bcl-2 expression in human melanocytes and melanocytic tumors.The American journal of pathology, 145 2
N. Lassam, S. Bickford (1992)
Loss of c-kit expression in cultured melanoma cells.Oncogene, 7 1
Julia Bosher, Trevor Williams, Helen Hurst (1995)
The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma.Proceedings of the National Academy of Sciences of the United States of America, 92 3
Christine Sers, Kathrin Kirsch, Ute Rothbalcher, Gert Riethmoller, Judith Johnson (1993)
Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains.Proceedings of the National Academy of Sciences of the United States of America, 90 18
E. Geissler, Melanie Ryan, D. Housman (1988)
The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogeneCell, 55
M. Luca, Suyun Huang, J. Gershenwald, Rakesh Singh, R. Reich, M. Bar‐eli (1997)
Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.The American journal of pathology, 151 4
B. Holzmann, E. Bröcker, J. Lehmann, D. Ruiter, C. Sorg, G. Riethmüller, Judith Johnson (1987)
Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypesInternational Journal of Cancer, 39
Katsuya Yamamoto, A. Tojo, N. Aoki, M. Shibuya (1993)
Characterization of the Promoter Region of the Human c‐kit Proto‐oncogeneJapanese Journal of Cancer Research : Gann, 84
P. Mitchell, Charlotte Wang, R. Tjian (1987)
Positive and negative regulation of transcription in vitro: Enhancer-binding protein AP-2 is inhibited by SV40 T antigenCell, 50
Suyun Huang, D. Jean, M. Luca, M. Tainsky, M. Bar‐eli (1998)
Loss of AP‐2 results in downregulation of c‐KIT and enhancement of melanoma tumorigenicity and metastasisThe EMBO Journal, 17
D. Jean, J. Gershenwald, Suyun Huang, M. Luca, Michael Hudson, M. Tainsky, M. Bar‐eli (1998)
Loss of AP-2 Results in Up-regulation ofMCAM/MUC18 and an Increase in Tumor Growth and Metastasis of Human Melanoma Cells*The Journal of Biological Chemistry, 273
Reinhard BUETfNER, P. Kannan, '. Imhof, Reinhard Bauer, Sun, 0., Yim, Rudolf Glockshuber, M. Dyke, Michael TAINSKYl (1993)
An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2Molecular and Cellular Biology, 13
G. Cowley, Mark Smith (1996)
CADHERIN EXPRESSION IN MELANOCYTIC NAEVI AND MALIGNANT MELANOMASThe Journal of Pathology, 179
P. Natali, M. Nicotra, G. Digiesi, R. Cavaliere, A. Bigotti, D. Trizio, O. Segatto (1994)
Expression of gp 185HER‐2 in human cutaneous melanoma: Implications for experimental immunotherapeuticsInternational Journal of Cancer, 56
Y. Yarden, W. Kuang, Yang-Feng Tl, L. Coussens, S. Munemitsu, T. Dull, E. Chen, J. Schlessinger, U. Francke, A. Ullrich (1987)
Human proto‐oncogene c‐kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.The EMBO Journal, 6
IJ Fidler (1990)
Critical factors in the biology of human cancer metastasisCancer Res, 50
B Holzmann, EB Brocker, JM Lehmann, DJ Rutter, C Sorg, G Riethmuller, JP Johnson (1987)
Tumor progression in human melanoma: five stages defined by their antigenic phenotypesInt J Cancer, 39
J. Karjalainen, J. Kellokoski, Eskelinen Mj, Esko Alhava, V. Kosma (1998)
Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 11
K. Nocka, S. Majumder, B. Chabot, P. Ray, 1. Cervone, A. Bernstein, P. Besmer (1989)
Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice.Genes & development, 3 6
S. Xie, M. Luca, Suyun Huang, M. Gutman, R. Reich, Judith Johnson, M. Bar‐eli (1997)
Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.Cancer research, 57 11
A. Kopf, T. Salopek, J. Slade, A. Marghoob, R. Bart (1995)
Techniques of cutaneous examination for the detection of skin cancerCancer, 75
P. Natali, M. Nicotra, A. Winkler, R. Cavaliere, A. Bigotti, A. Ullrich (1992)
Progression of human cutaneous melanoma is associated with loss of expression of c‐kit proto‐oncogene receptorInternational Journal of Cancer, 52
Isaiah Fidler (1995)
Critical factors in the biology of human cancer metastasis.The American surgeon, 61 12
B. Luscher, P. Mitchell, T. Williams, R. Tjian (1989)
Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers.Genes & development, 3 10
P. Mitchell, P. Timmons, J. Hébert, P. Rigby, R. Tjian (1991)
Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis.Genes & development, 5 1
山本 克也 (1994)
Characterization of the promoter region of the human c-kit proto-oncogene
J. Lehmann, G. Riethmuller, Judith JOHNSONt (1989)
MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily.Proceedings of the National Academy of Sciences of the United States of America, 86 24
Y. Zeng, K. Somasundaram, W. El-Deiry (1997)
AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expressionNature Genetics, 15
JM Lehmann, G Riethmuller, JP Johnson (1989)
MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamilyProc Natl Sci USA, 89
T. Williams, A. Admon, B. Lüscher, R. Tjian (1988)
Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements.Genes & development, 2 12A
A. Breslow (1970)
Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 172
C. Brannan, S. Lyman, Douglas Williams, J. Eisenman, Dirk Anderson, D. Cosman, M. Bedell, N. Jenkins, N. Copeland (1991)
Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains.Proceedings of the National Academy of Sciences of the United States of America, 88 11
Hongping Jiang, Jian Lin, Zao‐zhong Su, M. Herlyn, Robert Kerbel, Bernard Weissman, Danny Welch, Paul Fisher (1995)
The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.Oncogene, 10 9
T. Williams, R. Tjian (1991)
Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins.Science, 251 4997
JM Lehmann, B Holzmann, EW Breitbart, P Schmiegelow, G Riethmuller, JP Johnson (1987)
Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 76,000Cancer Res, 47
We previously demonstrated that expression of the cell surface adhesion molecule MCAM/MUC18 correlates directly with the metastatic potential of human melanoma cells. In addition, the progression of human melanoma towards the metastatic phenotype is associated with loss of expression of the tyrosine-kinase receptor c-KIT. This review summarizes our recent data demonstrating that the expression of both genes is regulated by the AP-2 transcription factor. Moreover, we have observed a loss of AP-2 expression in metastatic melanoma cells. Re-expression of AP-2 in the highly metastatic A375SM cells decreased their tumorigenicity and inhibited their metastatic potential in nude mice. MCAM/MUC18 mRNA and protein expression was significantly downregulated while c-kit expression was upregulated in the AP-2 transfected cells. Since AP-2 also regulates other genes that are involved in the progression of human melanoma such as E-cadherin, MMP-2, p21WAF-1, HER-2, BCL-2, and insulin like growth factor receptor-1, we propose that loss of AP-2 is a crucial event in the development of malignant melanoma.
Cancer and Metastasis Reviews – Springer Journals
Published: Sep 29, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.